Submitted by Anonymous (not verified) on 17 August 2023 - 16:12
Human medicines European public assessment report (EPAR): Nexpovio, selinexor, Multiple Myeloma, Date of authorisation: 26/03/2021, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Nexpovio, selinexor, Multiple Myeloma, Date of authorisation: 26/03/2021, Revision: 8, Status: Authorised